386
Views
33
CrossRef citations to date
0
Altmetric
Original Articles Research

Enhancing the in vitro cytotoxic activity of Δ9-tetrahydrocannabinol in leukemic cells through a combinatorial approach

, PhD, , , &
Pages 1800-1809 | Received 20 Mar 2008, Accepted 31 May 2008, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Olga Kovalchuk & Igor Kovalchuk. (2020) Cannabinoids as anticancer therapeutic agents. Cell Cycle 19:9, pages 961-989.
Read now
Venkatesh Rengaswamy, Udo Kontny & Jochen Rössler. (2011) New approaches for pediatric rhabdomyosarcoma drug discovery: targeting combinatorial signaling. Expert Opinion on Drug Discovery 6:10, pages 1103-1125.
Read now

Articles from other publishers (30)

Prateeksha Prateeksha, Vivek K. Sharma, Shiv M. Singh, Minaxi Sharma, Deepti Diwan, Abd El-Latif Hesham, Sanjay Guleria, Quang D. Nguyen, Vijai K. Gupta & Brahma N. Singh. (2023) Tetrahydrocannabinols: potential cannabimimetic agents for cancer therapy. Cancer and Metastasis Reviews 42:3, pages 823-845.
Crossref
Dingya Sun, Xin Li, Shengdan Nie, Jiajia Liu & Shan Wang. (2023) Disorders of cancer metabolism: The therapeutic potential of cannabinoids. Biomedicine & Pharmacotherapy 157, pages 113993.
Crossref
Ivan A. RossIvan A. Ross. 2023. Plant-Based Therapeutics, Volume 1. Plant-Based Therapeutics, Volume 1 427 511 .
Hilal Salcin, Bakiye Goker BagcaIlayda AlcitepeCigir Biray AvciRukiye AslanSerap Annette AkgurBurcin Tezcanli Kaymaz. (2022) Investigating the Effects of a Synthetic Cannabinoid on the Pathogenesis of Leukemia and Leukemic Stem Cells: A New Therapeutic Approach. Cannabis and Cannabinoid Research.
Crossref
Burkhard Hinz & Robert Ramer. (2022) Cannabinoids as anticancer drugs: current status of preclinical research. British Journal of Cancer 127:1, pages 1-13.
Crossref
Magdalena Schab & Szymon Skoczen. (2022) The Role of Nutritional Status, Gastrointestinal Peptides, and Endocannabinoids in the Prognosis and Treatment of Children with Cancer. International Journal of Molecular Sciences 23:9, pages 5159.
Crossref
John-Mark Fitzpatrick, Becky Hackett, Lisa Costelloe, William Hind & Eric J. Downer. (2022) Botanically-Derived Δ9-Tetrahydrocannabinol and Cannabidiol, and Their 1:1 Combination, Modulate Toll-like Receptor 3 and 4 Signalling in Immune Cells from People with Multiple Sclerosis. Molecules 27:6, pages 1763.
Crossref
Clara Andradas, Alexandra Truong, Jacob Byrne & Raelene Endersby. (2021) The Role of Cannabinoids as Anticancer Agents in Pediatric Oncology. Cancers 13:1, pages 157.
Crossref
Pratibha Malhotra, Ilaria Casari & Marco Falasca. (2021) Therapeutic potential of cannabinoids in combination cancer therapy. Advances in Biological Regulation 79, pages 100774.
Crossref
Louis-Philippe de Lorimier, Trina Hazzah, Erik Amazonas & Stephen Cital. 2021. Cannabis Therapy in Veterinary Medicine. Cannabis Therapy in Veterinary Medicine 231 269 .
Andrea M. Tomko, Erin G. Whynot, Lee D. Ellis & Denis J. Dupré. (2020) Anti-Cancer Potential of Cannabinoids, Terpenes, and Flavonoids Present in Cannabis. Cancers 12:7, pages 1985.
Crossref
John-Mark Fitzpatrick, Eleanor Minogue, Lucy Curham, Harry Tyrrell, Philip Gavigan, William Hind & Eric J. Downer. (2020) MyD88-dependent and -independent signalling via TLR3 and TLR4 are differentially modulated by Δ9-tetrahydrocannabinol and cannabidiol in human macrophages. Journal of Neuroimmunology 343, pages 577217.
Crossref
Danielle Brown, Michael Watson & Janet Schloss. (2019) Pharmacological evidence of medicinal cannabis in oncology: a systematic review. Supportive Care in Cancer 27:9, pages 3195-3207.
Crossref
Robert Ramer, Rico Schwarz & Burkhard Hinz. (2019) Modulation of the Endocannabinoid System as a Potential Anticancer Strategy. Frontiers in Pharmacology 10.
Crossref
Burkhard Hinz & Robert Ramer. (2019) Anti-tumour actions of cannabinoids. British Journal of Pharmacology 176:10, pages 1384-1394.
Crossref
Estefanía Moreno, Milena Cavic, Ana Krivokuca, Vicent Casadó & Enric Canela. (2019) The Endocannabinoid System as a Target in Cancer Diseases: Are We There Yet?. Frontiers in Pharmacology 10.
Crossref
Sheng-Wei Chang, Jack Wellmerling, Xiaoli Zhang, Rachael E. Rayner, Wissam Osman, Sara Mertz, Amal O. Amer, Mark E. Peeples, Prosper N. Boyaka & Estelle Cormet-Boyaka. (2018) The psychoactive substance of cannabis Δ9-tetrahydrocannabinol (THC) negatively regulates CFTR in airway cells. Biochimica et Biophysica Acta (BBA) - General Subjects 1862:9, pages 1988-1994.
Crossref
Eric P. Baron. (2018) Medicinal Properties of Cannabinoids, Terpenes, and Flavonoids in Cannabis, and Benefits in Migraine, Headache, and Pain: An Update on Current Evidence and Cannabis Science. Headache: The Journal of Head and Face Pain 58:7, pages 1139-1186.
Crossref
Višnja BogdanovićJasminka MrdjanovićIvana Borišev. (2017) A Review of the Therapeutic Antitumor Potential of Cannabinoids. The Journal of Alternative and Complementary Medicine 23:11, pages 831-836.
Crossref
Caroline Diorio, Kristen Salena, Elena J. Ladas, Catherine G. Lam, Glenn M. Afungcwhi, Festus Njuguna & Stacey Marjerrison. (2017) Traditional and complementary medicine used with curative intent in childhood cancer: A systematic review. Pediatric Blood & Cancer 64:9, pages e26501.
Crossref
Katherine A. Scott, Angus G. Dalgleish & Wai M. Liu. (2017) Anticancer effects of phytocannabinoids used with chemotherapy in leukaemia cells can be improved by altering the sequence of their administration. International Journal of Oncology 51:1, pages 369-377.
Crossref
Robert Ramer & Burkhard Hinz. 2017. Cannabinoid Pharmacology. Cannabinoid Pharmacology 397 436 .
Massimo Nabissi, Maria Beatrice Morelli, Massimo Offidani, Consuelo Amantini, Silvia Gentili, Alessandra Soriani, Claudio Cardinali, Pietro Leoni & Giorgio Santoni. (2016) Cannabinoids synergize with carfilzomib, reducing multiple myeloma cells viability and migration. Oncotarget 7:47, pages 77543-77557.
Crossref
Katherine A. Scott, Angus G. Dalgleish & Wai M. Liu. (2014) The Combination of Cannabidiol and Δ9-Tetrahydrocannabinol Enhances the Anticancer Effects of Radiation in an Orthotopic Murine Glioma Model. Molecular Cancer Therapeutics 13:12, pages 2955-2967.
Crossref
Bandana Chakravarti, Janani Ravi & Ramesh K. Ganju. (2014) Cannabinoids as therapeutic agents in cancer: current status and future implications. Oncotarget 5:15, pages 5852-5872.
Crossref
Clementina Manera, Giuseppe Saccomanni, Anna Maria Malfitano, Simone Bertini, Francesca Castelli, Chiara Laezza, Alessia Ligresti, Valentina Lucchesi, Tiziano Tuccinardi, Flavio Rizzolio, Maurizio Bifulco, Vincenzo Di Marzo, Antonio Giordano, Marco Macchia & Adriano Martinelli. (2012) Rational design, synthesis and anti-proliferative properties of new CB2 selective cannabinoid receptor ligands: An investigation of the 1,8-naphthyridin-2(1H)-one scaffold. European Journal of Medicinal Chemistry 52, pages 284-294.
Crossref
Wai M. Liu, Andrew M. Gravett & Angus G. Dalgleish. (2010) The antimalarial agent artesunate possesses anticancer properties that can be enhanced by combination strategies. International Journal of Cancer 128:6, pages 1471-1480.
Crossref
Andrew M. Gravett, Wai M. Liu, Sanjeev Krishna, Wing-Chi Chan, Richard K. Haynes, Natalie L. Wilson & Angus G. Dalgleish. (2010) In vitro study of the anti-cancer effects of artemisone alone or in combination with other chemotherapeutic agents. Cancer Chemotherapy and Pharmacology 67:3, pages 569-577.
Crossref
Susanne Oesch & Jürg Gertsch. (2009) Cannabinoid receptor ligands as potential anticancer agents — high hopes for new therapies?. Journal of Pharmacy and Pharmacology 61:7, pages 839-853.
Crossref
W M Liu, D W Fowler, P Smith & A G Dalgleish. (2009) Pre-treatment with chemotherapy can enhance the antigenicity and immunogenicity of tumours by promoting adaptive immune responses. British Journal of Cancer 102:1, pages 115-123.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.